SCHEMBL21744246

SCHEMBL21744246

c1cnc(N2CCN(c3cccc4c3CCNC4)CC2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
TLR9 Q9NR96 1/20 0.47
TLR7 Q9NYK1 1/20 0.47
GAA P10253 1/20 0.47
HTT P42858 1/20 0.47
CYP3A4 P08684 3/20 0.45
CYP2D6 P10635 3/20 0.45
CHRM2 P08172 3/20 0.45
CHRM4 P08173 3/20 0.45
CHRM5 P08912 3/20 0.45
CHRM1 P11229 3/20 0.45
CHRM3 P20309 3/20 0.45
CXCR4 P61073 3/20 0.45
CD44 P16070 1/20 0.45
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
HTR2C P28335 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21743757 0.85 PLD1 (0.52) SMN1; SMN2TLR9TLR7GAACYP3A4
SCHEMBL16485203 0.82 CD44 (0.50) TLR9TLR7CD44HTR2CHTR2A
SCHEMBL21744394 0.82 HTR2C (0.54) CYP2D6CD44ALDH1A1KDM4ELMNA
SCHEMBL21744250 0.80 CHRM2 (0.52) TLR9TLR7CYP3A4CYP2D6CHRM2
SCHEMBL1011153 0.78 CD44 (0.49) TLR9TLR7CYP3A4CYP2D6CD44
SCHEMBL21743762 0.78 CD44 (0.45) TLR9TLR7CYP3A4CYP2D6CXCR4
SCHEMBL21744598 0.78 CD44 (0.45) TLR9TLR7CYP2D6CXCR4CD44
SCHEMBL21744256 0.78 DRD2 (0.47) TLR9TLR7CXCR4CD44HTR2C
SCHEMBL21744605 0.76 CD44 (0.46) TLR9TLR7GAACHRM2CHRM4
SCHEMBL21744697 0.76 CD44 (0.46) TLR9TLR7CYP3A4CYP2D6CD44

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto UNIV EMORY (US) 2023-04-13 US disclosed
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto EMORY UNIVERSITY 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 POLB 3104/4885SMN1; SMN2 4199/4885TLR9 138/4885
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 POLB 3104/4885SMN1; SMN2 4199/4885TLR9 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.